Abstract
Despite previous findings of therapeutic effects for heart rate variability biofeedback (HRVB) on asthma, it is not known whether HRVB can substitute either for controller or rescue medication, or whether it affects airway inflammation. Sixty-eight paid volunteer steroid naïve study participants with mild or moderate asthma were given 3 months of HRVB or a comparison condition consisting of EEG alpha biofeedback with relaxing music and relaxed paced breathing (EEG+), in a two-center trial. All participants received a month of intensive asthma education prior to randomization. Both treatment conditions produced similar significant improvements on the methacholine challenge test (MCT), asthma symptoms, and asthma quality of life (AQOL). MCT effects were of similar size to those of enhanced placebo procedures reported elsewhere, and were 65% of those of a course of a high-potency inhaled steroid budesonide given to a sub-group of participants following biofeedback training. Exhaled nitric oxide decreased significantly only in the HRVB group, 81% of the budesonide effect, but with no significant differences between groups. Participants reported becoming more relaxed during practice of both techniques. Administration of albuterol after biofeedback sessions produced a large improvement in pulmonary function test results, indicating that neither treatment normalized pulmonary function as a potent controller medication would have done. Impulse oscillometry showed increased upper airway (vocal cord) resistance during biofeedback periods in both groups. These data suggest that HRVB should not be considered an alternative to asthma controller medications (e.g., inhaled steroids), although both biofeedback conditions produced some beneficial effects, warranting further research, and suggesting potential complementary effects. Various hypotheses are presented to explain why HRVB effects on asthma appeared smaller in this study than in earlier studies. Clinical Trial Registration NCT02766374.
Similar content being viewed by others
Abbreviations
- ACT:
-
Asthma Control Test
- AQOL:
-
Juniper’s Asthma Quality of Life Questionnaire with Standardized Activities
- AX:
-
A forced oscillation measure of lung reactance
- EEG+:
-
The comparison condition, comprising EEG biofeedback, relaxing music, and relaxed paced breathing at ~ 15 breaths/min
- EPAC:
-
Episodes of poor asthma control
- eNO:
-
Exhaled nitric oxide
- FEV1 :
-
Quantity of air exhaled in the first second of a forced expiratory maneuver from maximum vital capacity
- FVC:
-
Total air exhaled in a forced expiratory maneuver from maximum vital capacity
- GEE:
-
Generalized estimating equation
- HRV:
-
Heart rate variability
- HRVB:
-
Heart rate variability biofeedback
- ICS:
-
Inhaled corticosteroids
- IOS:
-
Impulse oscillometry system
- LS mean:
-
Least square mean
- MCT:
-
Methacholine challenge test
- NJH:
-
National Jewish Health
- PC20FEV1 :
-
The dose of methacholine at which a 20% decrease in FEV1 occurs
- PEF:
-
Peak expiratory flow during a forced airway maneuver
- RSA:
-
Respiratory sinus arrhythmia
- RWJMS:
-
Robert Wood Johnson Medical School
References
Aboussafy, D., Campbell, T. S., Lavoie, K., Aboud, F. E., & Ditto, B. (2005). Airflow and autonomic responses to stress and relaxation in asthma: The impact of stressor type. International Journal of Psychophysiology, 57(3), 195–201.
Alving, K., Weitzberg, E., & Lundberg, J. M. (1993). Increased amount of nitric oxide in exhaled air of asthmatics. European Respiratory Journal, 6, 1368–1370.
Barnes, P. J., & Liew, F. Y. (1995). Nitric oxide and asthmatic inflammation. Immunology Today, 16(3), 128–130.
Berntson, G. G., Bigger, J. T., Eckberg, D. L., Grossman, P., Kaufman, P. G., Malik, M., … van der Molen, M. W. (1997). Heart rate variability: Origins, methods, and interpretive caveats. Psychophysiology, 34, 623–648.
Beydon, N., Davis, S. D., Lombardi, E., Allen, J. L., Arets, H. G., & Aurora, P. (2007). Young children pulmonary function. An official American Thoracic Society/European Respiratory Society statement: Pulmonary function testing in preschool children. American Journal of Respiratory & Critical Care Medicine, 175(12), 1304–1345. T.
Brusasco, V., & Crimi, E. (2001). Methacholine provocation test for diagnosis of allergic respiratory diseases. Allergy, 56(12), 1114–1120.
Brusasco, V., Crimi, E., & Pellegrino, R. (1998). Airway hyperresponsiveness in asthma: Not just a matter of airway inflammation. Thorax, 53(11), 992–998.
Crapo, R. O., Casaburi, R., Coates, A. L., Enright, P. L., Hankinson, J. L., Irvin, C. G., … Sterk, P. J. (2000). Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. American Journal of Respiratory & Critical Care Medicine, 161(1), 309–329.
Davis, B. E., & Cockcroft, D. W. (2012). Past, present and future uses of methacholine testing. Expert Review of Respiratory Medicine, 6(3), 321–329.
Deviliya, G. J., & Borkovec, T. D. (2000). Psychometric properties of the credibility/expectancy questionnaire. Journal of Behavior Therapy & Experimental Psychiatry, 31(2), 73–86.
Deykin, A., Massaro, A. F., Drazen, J. M., & Israel, E. (2002). Exhaled nitric oxide as a diagnostic test for asthma: Online versus offline techniques and effect of flow rate. American Journal of Respiratory & Critical Care Medicine, 165(12), 1597–1601.
Eckberg, D. L., & Sleight, P. (1992). Human baroreflexes in health and disease. Gloustershire: Clarendon Press.
Feldman, J. M., Lehrer, P. M., Hochron, S. M., & Schwartz, G. E. (2002). Defensiveness and individual response stereotypy in asthma. Psychosomatic Medicine, 64(2), 294–301.
Fonseca, J. A., Costa-Pereira, A., Delgado, L., Silva, L. N., Magalhaes, M., Castel-Branco, M. G., & Vaz, M. (2005). Pulmonary function electronic monitoring devices: A randomized agreement study. Chest, 128(3), 1258–1265.
Freitas, D. A., Holloway, E. A., Bruno, S. S., Chaves, G. S., Fregonezi, G. A., & Mendonca, K. P. (2013). Breathing exercises for adults with asthma. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001277.pub3
Grrishma, B., Gaur, G. S., Velkumary, S., Subramanian, S. K., & Gurunandan, U. (2015). Assessment of cardiovascular autonomic functions and baroreceptor reactivity in women with premenstrual syndrome. Indian Journal of Physiology & Pharmacology, 59(2), 148–154.
Guo, Z., Wang, Y., Xing, G., & Wang, X. (2016). Diagnostic accuracy of fractional exhaled nitric oxide in asthma: A systematic review and meta-analysis of prospective studies. Journal of Asthma, 53(4), 404–412.
Hafez, M. R., Abu-Bakr, S. M., & Mohamed, A. A. (2015). Forced oscillometry track sites of airway obstruction in bronchial asthma. Annals of Allergy, Asthma, & Immunology, 115(1), 28–32.
Hewitt, D. J. (2008). Interpretation of the “positive” methacholine challenge. American Journal of Industrial Medicine, 51(10), 769–781.
Hoyte, F. C. L. (2013). Vocal cord dysfunction. Immunology and Allergy Clinics of North America, 33(1), 1–22.
Irvin, C. G., Martin, R. J., Chinchilli, V. M., Kunselman, S. J., & Cherniack, R. M. (1997). Quality control of peak flow meters for multicenter clinical trials. The asthma clinical research network (ACRN). American Journal of Respiratory & Critical Care Medicine, 156(2 Pt 1), 396–402.
Isenberg, S. A., Lehrer, P. M., & Hochron, S. (1992). The effects of suggestion and emotional arousal on pulmonary function in asthma: A review and a hypothesis regarding vagal mediation. Psychosomatic Medicine, 54(2), 192–216.
James, A., & Ryan, G. (1997). Testing airway responsiveness using inhaled methacholine or histamine. Respirology, 2(2), 97–105.
Jatakanon, A., Kharitonov, S., Lim, S., & Barnes, P. J. (1999). Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax, 54(2), 108–114.
Jennings, J. R., Kamarck, T., Stewart, C., Eddy, M., & Johnson, P. (1992). Alternate cardiovascular baseline assessment techniques: Vanilla or resting baseline. Psychophysiology, 29(6), 742–750.
Jonasson, G., Carlsen, K. H., Jonasson, C., & Mowinckel, P. (2000). Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma. Allergy, 55(8), 740–748.
Juniper, E. F., Buist, A. S., Cox, F. M., Ferrie, P. J., & King, D. R. (1999). Validation of a standardized version of the asthma quality of life questionnaire. Chest, 115, 1265–1270.
Juniper, E. F., Guyatt, G. H., Ferrie, P. J., & Griffith, L. E. (1993). Measuring quality of life in asthma. American Review of Respiratory Disease, 147(4), 832–838.
Kemeny, M. E., Rosenwasser, L. J., Panettieri, R. A., Rose, R. M., Berg-Smith, S. M., & Kline, J. N. (2007). Placebo response in asthma: A robust and objective phenomenon. Journal of Allergy & Clinical Immunology, 119(6), 1375–1381.
Langmack, E. L. (2001). Complimentary and alternative therapies for asthma. In S. J. Szefler & D.Y.M. Leung (Eds.), Severe asthma, pathogenesis and clinical management (2nd edn., pp. 221–238). New York: Marcel Dekker.
Lehrer, P. M. (2012). Biofeedback therapy for asthma. In R. Anbar (Ed.), Functional respiratory disorders. New York: Springer.
Lehrer, P. M., Hochron, S. M., Mayne, T., Isenberg, S., Carlson, V., Lasoski, A. M., … Rausch, L. (1994). Relaxation and music therapies for asthma among patients prestabilized on asthma medication. Journal of Behavioral Medicine, 17(1), 1–24.
Lehrer, P. M., Hochron, S. M., Mayne, T., Isenberg, S., Lasoski, A. M., Carlson, V., … Porges, S. (1997). Relationship between changes in EMG and respiratory sinus arrhythmia in a study of relaxation therapy for asthma. Applied Psychophysiology and Biofeedback, 22(3), 183–191.
Lehrer, P. M., Hochron, S. M., McCann, B., Swartzman, L., & Reba, P. (1986). Relaxation decreases large-airway but not small-airway asthma. Journal of Psychosomatic Research, 30(1), 13–25.
Lehrer, P. M., Vaschillo, B., Zucker, T., Graves, J., Katsamanis, M., Aviles, M., & Wamboldt, F. S. (2013). Protocol for heart rate variability biofeedback training. Biofeedback, 41(3), 98–109.
Lehrer, P. M., Vaschillo, E. G., Vaschillo, B., Lu, S.-E., Eckberg, D. L., Edelberg, R., … Hamer, R. M. (2003). Heart rate variability biofeedback increases baroreflex gain and peak expiratory flow. Psychosomatic Medicine, 65(5), 796–805.
Lehrer, P. M., Vaschillo, E. G., Vaschillo, B., Lu, S.-E., Scardella, A., Siddique, M., & Habib, R. H. (2004). Biofeedback treatment for asthma. Chest, 126(2), 352–361.
Malmberg, L. P., Pelkonen, A. S., Haahtela, T., & Turpeinen, M. (2003). Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax, 58, 494–499.
McCulloch, C. E., Searle, S. R., & Neuhaus, J. M. (2001). Generalized, linear, and mixed models. New York: Wiley.
Milgrom, H., Bender, B. G., Ackerson, L., Bowry, P., Smith, B., & Rand, C. (1996). Noncompliance and treatment failure in children with asthma. Journal of Allergy and Clinical Immunology, 98, 1051–1057.
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A. ... Force, A. E. T. (2005). Standardisation of spirometry. European Respiratory Journal, 26(2), 319–338.
Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., … Pendergraft, T. B. (2004). Development of the asthma control test: a survey for assessing asthma control. Journal of Allergy & Clinical Immunology, 113(1), 59–65.
National Heart Lung and Blood Institute (NHLBI). (2007). Expert panel report 3: Guidelines for the diagnosis and management of asthma: Full report. Washington, DC: National Asthma Education and Prevention Program, Department of Health and Human Services.
Pavlov, V. A., & Tracey, K. J. (2006). Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochemical Society Transactions, 34(Pt 6), 1037–1040.
Porges, S. W. (1995). Orienting in a defensive world: mammalian modifications of our evolutionary heritage. A Polyvagal Theory. Psychophysiology, 32, 301–318.
Porges, S. W. (2001). The polyvagal theory: Phylogenetic substrates of a social nervous system. International Journal of Psychophysiology, 42, 123–146.
Porges, S. W. (2007). The polyvagal perspective. Biological Psychology, 74(2), 116–143.
Rowe, B. H., & Oxman, A. D. (1993). Performance of an asthma quality of life questionnaire in an outpatient setting. American Review of Respiratory Disease, 148(3), 675–681.
Schatz, M., Mosen, D. M., Kosinski, M., Vollmer, W. M., Magid, D. J., O’Connor, E., & Zeiger, R. S. (2007). Validity of the asthma control test completed at home. American Journal of Managed Care, 13(12), 661–667.
Schatz, M., Sorkness, C. A., Li, J. T., Marcus, P., Murray, J. J., Nathan, R. A., … Jhingran, P. (2006). Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. Journal of Allergy & Clinical Immunology, 117(3), 549–556.
Sheffer, A. L., & Taggart, V. S. (1993). The National asthma education program. Expert panel report guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. Medical Care, 31(3 Suppl), MS20-28.
Silkoff, P. E., Stevens, A., Pak, J., Bucher-Bartelson, B., & Martin, R. J. (1999). A method for the standardized offline collection of exhaled nitric oxide. Chest, 116(3), 754–759.
Smith, J. C. (2001). Advances in ABC relaxation theory: The 14 + 1 map advances in ABC relaxation: Applications and inventories (pp. 3–32). New York, NY: Springer.
Smith, L. J., Kalhan, R., Wise, R. A., Sugar, E. A., Lima, J. J., & Irvin, C. G. … American Lung Association Asthma Clinical Research, C. (2015). Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial. JAMA: The journal of the American Medical Association, 313(20), 2033–2043.
Song, H.-S., & Lehrer, P. M. (2003). The effects of specific respiratory rates on heart rate and heart rate variability. Applied Psychophysiology & Biofeedback, 28(1), 13–23.
Strunk, R. C., Ford, J. G., & Taggart, V. (2002). Reducing disparities in asthma care: Priorities for research–National Heart, Lung, and Blood Institute workshop report. Journal of Allergy and Clinical Immunology, 109, 229–237.
Van Buren, T., Kasbergen, C. M., Gispen, W. H., & De Wildt, D. J. (1998). In vivo cardiovascular reactivity and baroreflex activity in diabetic rats. Cardiovascular Research, 38(3), 763–771.
Vaschillo, E. G., Lehrer, P. M., Rishe, N., & Konstantinov, M. (2002). Heart rate variability biofeedback as a method for assessing baroreflex function: a preliminary study of resonance in the cardiovascular system. Applied Psychophysiology & Biofeedback, 27(1), 1–27.
Vaschillo, E. G., Vaschillo, B., & Lehrer, P. M. (2006). Characteristics of resonance in heart rate variability stimulated by biofeedback. Applied Psychophysiology & Biofeedback, 31(2), 129–142.
Wamboldt, F. S., & Balkissoon, R. C. (2008). Vocal cord dysfunction. In M. Castro & M. Kraft (Eds.), Clinical asthma (pp. 345–350). Philadelphia: Elsevier.
Williams, L. K., Pladevall, M., Xi, H., Peterson, E. L., Joseph, C., Lafata, J. E., Ownby, D. R., & Johnson, C. C. (2004). Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. Journal of Allergy and Clinical Immunology, 114, 1288–1293.
Wise, R. A., Bartlett, S. J., Brown, E. D., Castro, M., Cohen, R., & Holbrook, J. T. … American Lung Association Asthma Clinical Research, C. (2009). Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. Journal of Allergy & Clinical Immunology, 124(3), 436–444.
World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization.
Acknowledgements
This research was funded by National Institutes of Health – National Heart Lung and Blood Institute Grant #R01 HL089495, and at the National Jewish site was supported by NIH/NCATS Colorado CTSI Grant Number UL1 TR001082. Contents are the sole responsibility of the authors and do not necessarily represent official NIH views. The study was approved by the institutional review boards of Rutgers Robert Wood Johnson Medical School # 0220080228 and National Jewish Health # 17604.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No author has a financial conflict of interest with material in this paper.
Rights and permissions
About this article
Cite this article
Lehrer, P.M., Irvin, C.G., Lu, SE. et al. Heart Rate Variability Biofeedback Does Not Substitute for Asthma Steroid Controller Medication. Appl Psychophysiol Biofeedback 43, 57–73 (2018). https://doi.org/10.1007/s10484-017-9382-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10484-017-9382-0